SearcharxivSearch

arXiv subjects

Ante Bing

Publications and source records attributed to Ante Bing.

4 recordsLinked to original sources

Addressing Confounding by Indication Through (Un)Measured Centre Characteristics in Learn-As-you-GO(LAGO) Trials

The Learn-As-you-Go (LAGO) design is an adaptive clinical trial design allowing modifications to multicomponent intervention packages across stages. Centers participate in more than one stage, as is common in large-scale implementation trials. In LAGO trials, center characteristics may act as confounders, predicting both the intervention package and the outcomes. We extend LAGO theory by introducing fixed center effects to control for confounding by indication through measured and unmeasured center characteristics. Conditioning on center characteristics by including fixed center effects ensures asymptotic results hold without requiring explicit characterization of unmeasured confounders. Our methods apply even with small numbers of centers. LAGO theory is established for continuous outcomes following a generalized linear model and binary outcomes following a logistic regression model, unifying theory across outcome types. Point- and interval estimators are derived, and consistency and asymptotic normality are established. Valid hypothesis tests for the overall intervention effect are provided, and the optimal intervention package minimizing cost subject to a target outcome mean is obtained via constrained optimization.

stat.ME

Optimizing Complex Health Intervention Packages through the Learn-As-you-GO (LAGO) Design

In the face of vast numbers of preventable deaths worldwide and gaping disparities in their distribution, we cannot afford to conduct null and inconclusive effectiveness and implementation trials of evidence-based interventions. The gold standard in biomedical research, the individually randomized clinical trial, is ill-suited as the primary tool for knowledge generation for contextually relevant, scalable, complex public health interventions of multi-component strategies. In this paper, we discuss the new Learn-As-you-GO (LAGO) design. In LAGO trials, the components of a complex intervention package are repeatedly optimized in pre-planned stages, until the package achieves its outcome and power goals with minimized cost and/or other optimization criteria, such as maximizing patient satisfaction. In this paper, the inputs to, and outputs of, LAGO are described, along with its general methodology. The methods are illustrated in the BetterBirth study, a large trial that aimed to reduce maternal and neonatal mortality in Uttar Pradesh, India, using the WHO essential birth practices checklist. Despite its scale, the BetterBirth study failed to demonstrate a significant effect of the intervention package on the primary health endpoint that included maternal mortality. We show how this unfortunate outcome could have been remedied had LAGO been used. LAGO is further illustrated through the discussion of several ongoing LAGO-informed implementation trials of HIV and non-communicable diseases in the United States and Sub-Saharan Africa. The Learn-As-you-GO (LAGO) design optimizes a complex, multi-level intervention for minimum cost, pre-specified power, and a pre-specified effectiveness goal, by adapting the intervention as the study is conducted, reducing risk of trial failure.

stat.ME

Learn-As-you-GO (LAGO) Trials: Optimizing Trials for Effectiveness and Power to Prevent Failed Trials

The Learn-As-you-GO (LAGO) design provides a rigorous framework for adapting the intervention package based on accumulating data while the trial is ongoing. This article improves the flexibility of the LAGO design by incorporating statistical power as an optimization criterion (power goal) in LAGO optimizations. We propose the unconditional and conditional power approaches to add a power goal. Both approaches estimate the power at the end of the LAGO trial using data from prior stages, and increase the power at the end of the LAGO trial when the original trial was underpowered. Including a power goal maintains the asymptotic properties of the estimators of the treatment effect while preserving the asymptotic level of the statistical test at the end of the trial. We illustrate the benefits of our methods through a retrospective application to the BetterBirth Study, a large-scale study of maternal-newborn care that failed to show a significant effect on its primary outcome. This analysis demonstrates how our methods could have led to more intensive interventions and potentially significant results. The LAGO design with power goal optimizations provides investigators with a powerful tool to reduce the risk of failed trials due to insufficient power.

stat.ME

Learn-As-you-GO (LAGO) Trials: Optimizing Treatments and Preventing Trial Failure Through Ongoing Learning

It is well known that changing the intervention package while a trial is ongoing does not lead to valid inference using standard statistical methods. However, it is often necessary to adapt, tailor, or tweak a complex intervention package in public health implementation trials, especially when the intervention package does not have the desired effect. This article presents conditions under which the resulting analyses remain valid even when the intervention package is adapted while a trial is ongoing. Our results on such Learn-As-you-GO (LAGO) studies extend the theory of LAGO for binary outcomes following a logistic regression model (Nevo, Lok and Spiegelman, 2021) to LAGO for continuous outcomes under flexible conditional mean model. We derive point and interval estimators of the intervention effects and ensure the validity of hypothesis tests for an overall intervention effect. We develop a confidence set for the optimal intervention package, which achieves a pre-specified mean outcome while minimizing cost, and confidence bands for the mean outcome under all intervention package compositions. This work will be useful for the design and analysis of large-scale intervention trials where the intervention package is adapted, tailored, or tweaked while the trial is ongoing.

stat.ME